ANIXA BIOSCIENCES, INC. Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31)
ANIXA BIOSCIENCES, INC. (ANIX) reported Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) of 0.20% for the 0-month period ending 2013-04-30, per its 10-Q/A filed 2013-06-19.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssumptionsRiskFreeInterestRate · last filed 2013-06-19
- ANIXA BIOSCIENCES, INC. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for fiscal 2012 was 1.16%, a 31.82% increase from fiscal 2011.
- ANIXA BIOSCIENCES, INC. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for fiscal 2011 was 0.88%.
| Period end | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 0 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 12 month |
|---|---|---|
| 2013-04-30 | 0.20% 10-Q/A · filed 2013-06-19 | |
| 2013-01-25 | 0.40% 10-Q/A · filed 2013-06-19 | |
| 2012-10-31 | 1.16% 10-K · filed 2013-01-29 | |
| 2011-10-31 | 0.88% 10-K · filed 2013-01-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |